Latka logo
Visiopharm logo

Visiopharmrevenue & funding

Other Analytics SoftwareHoersholm, DenmarkFounded 2001CEO Michael Grunkin

Visiopharm is an Other Analytics Software company based in Hoersholm, founded in 2001.

visiopharm.comLinkedInUpdated Dec 23, 2024
Annual revenue
$9M
Oct 2024EST.
Total raised
$15.5M
1 round
Employees
96
Dec 2024

Visiopharm revenue

Visiopharm has not published its revenue. GetLatka estimates it at about $9M a year (October 2024).

$0
$2.5M
$5M
$7.5M
$6.5M
–
$7.1M
$9M
2021202220232024
ReportedEstimateOne figure per year; a reported figure wins over an estimate
All 3 revenue readings, with sources
As ofRevenueSource
Apr 2021$6.5M–
Dec 2023$7.1MEST.GetLatka estimate
Oct 2024$9MEST.GetLatka estimate

– source not recorded

Visiopharm funding rounds & investors

Visiopharm has raised $15.5M in one round, in August 2018.

DateRoundRaised
Aug 2018Funding round$15.5M
Total raised$15.5M

Visiopharm CEO, founders & employees

Michael Grunkin founded Visiopharm in 2001 and runs it as CEO. Visiopharm had 96 employees (December 2024, LinkedIn), down from 105 a year earlier.

0
50
100
115
108
105
96
2021202220232024
ReportedOne figure per year; a reported figure wins over an estimate
All 6 headcount readings, with sources
As ofEmployeesSource
Dec 202496LinkedIn
Oct 202499LinkedIn
Dec 2023105LinkedIn
Dec 2022108LinkedIn
Dec 2021115LinkedIn
Apr 2021102–

Visiopharm FAQ

What is Visiopharm's revenue?

GetLatka estimates Visiopharm's revenue at about $9M a year (October 2024). The company hasn't published its own figure.

How much funding has Visiopharm raised?

Visiopharm has raised $15.5M in one funding round, in August 2018.

How many employees does Visiopharm have?

Visiopharm had 96 employees in December 2024, according to LinkedIn.

Who is the CEO of Visiopharm?

Michael Grunkin is the CEO of Visiopharm and founded the company in 2001.

Who founded Visiopharm?

Michael Grunkin founded Visiopharm in 2001.

How this page is sourced

5 from public sources · 2 estimates. Founder figures link to the second they were said; public figures name their source; estimates are marked EST. and say whose they are. Not financial advice.

Updated Dec 23, 2024Data disclaimerReport a correctionClaim this profileRun Visiopharm? Join the podcast